Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Alzheimer'S & Dementia (New York, N. Y.)|April 20, 2026
Neuroprotection trial design in progressive supranuclear palsy: challenges and solutionsLawrence I Golbe, Ronald G Thomas
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 27, 2016
Longitudinal decline in mild-to-moderate Alzheimer's disease: Analyses of placebo data from clinical trialsRonald G Thomas, Marilyn Albert, Ronald C Petersen, et al.
Frontiers in Digital Health|October 29, 2021
Optimizing Aggregated N-Of-1 Trial Designs for Predictive Biomarker Validation: Statistical Methods and Theoretical FindingsRebecca C Hendrickson, Ronald G Thomas, Nicholas J Schork, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 13, 2008
Ametropia, preschoolers' cognitive abilities, and effects of spectacle correctionAnne-Catherine Roch-Levecq, Barbara L Brody, Ronald G Thomas, et al.
Archives of Neurology|February 13, 2003
Estrogen levels do not correlate with improvement in cognitionLeon J Thal, Ronald G Thomas, Ruth Mulnard, et al.
Journal of Alzheimer'S Disease : JAD|January 15, 2019
Memantine and Acetylcholinesterase Inhibitor Use in Alzheimer's Disease Clinical Trials: Potential for Confounding by IndicationBranko N Huisa, Ronald G Thomas, Shelia Jin, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 12, 2005
Self-management of age-related macular degeneration at the 6-month follow-up: a randomized controlled trialBarbara L Brody, Anne-Catherine Roch-Levecq, Ronald G Thomas, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|August 3, 2002
Investigating emergent symptomatology as an outcome measure in a behavioral study of Alzheimer's diseaseRochelle E Tractenberg, Anthony Gamst, Ronald G Thomas, et al.
Neurology|September 8, 2019
Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trialLon S Schneider, Yona Geffen, Jonathan Rabinowitz, et al.
Alzheimer Disease and Associated Disorders|October 6, 2010
Adding delayed recall to the Alzheimer Disease Assessment Scale is useful in studies of mild cognitive impairment but not Alzheimer diseaseMary Sano, Rema Raman, Jennifer Emond, et al.
Pageof 9